📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Avidity Biosciences Inc

Common Name
Avidity Biosciences
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
391
Ticker
RNA
Exchange
NASDAQ/NMS
Description
Avidity Biosciences Inc. is a biotechnology company focused on the development of innovative therapies for unmet medical needs. The primary aim of Avidity is to harness its proprietary Antibody Oligon...

Avidity Biosciences's Financial Statements Preview

Below are the financial statements of Avidity Biosciences, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in thousands of USD
2024 as of 2024-12-31
2023 as of 2023-12-31
Assets
Current assets
Cash and cash equivalents
219,868a
185,082a
Marketable securities
1,281,629a
410,269a
Prepaid and other assets
40,793a
15,956a
Total current assets
1,542,290a
611,307a
Property and equipment, net
12,670a
8,381a
Restricted cash
2,795a
295a
Right-of-use assets
5,619a
8,271a
Other assets
521a
301a
Total assets
1,563,895a
628,555a
Current liabilities
Accounts payable and accrued liabilities
69,524a
34,341a
Accrued compensation
3,663a
14,335a
Lease liabilities, current portion
3,844a
3,639a
Deferred revenue, current portion
20,987a
28,365a
Total current liabilities
98,018a
80,680a
Lease liabilities, net of current portion
2,957a
6,213a
Deferred revenue, net of current portion
37,961a
40,898a
Total liabilities
138,936a
127,791a
Stockholders’ equity
Common stock
12a
8a
Additional paid-in capital
2,315,111a
1,071,395a
Accumulated other comprehensive income
2,902a
125a
Accumulated deficit
-893,066a
-570,764a
Total stockholders’ equity
1,424,959a
500,764a
Total liabilities and stockholders’ equity
1,563,895a
628,555a
Download Data

Verified Sources Behind Avidity Biosciences’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Avidity Biosciences’s data sources below and access millions more through our Disclosure Search.

a. Avidity Biosciences's 10-K 2024
a. Avidity Biosciences's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?